Key facts
- Ruiying Asset Management is a other based in Hangzhou, Zhejiang with 4 tracked portfolio companies.
- Notable positions include Biosion, Newrite Medical, Arthur Pharma, Biosun Pharma.
About Ruiying Asset Management
Ruiying Asset Management is a private investment fund based in Hangzhou, China. Established in 2017, the fund's business type is private equity investment funds, private equity investment FOF funds, venture capital funds, and venture capital FOF funds. The assets are managed by the executive management team.
Free account
See the whole book
- ·Watchlist + alerts for Ruiying Asset Management's activity
Create free account
No card required
Portfolio, priced
4 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Biosion | — | $182.3M | — | |
| Newrite Medical | — | $32.7M | — | |
| Arthur Pharma | — | — | — | |
| Biosun Pharma | — | — | — |
Frequently asked
- What companies does Ruiying Asset Management invest in?
- Ruiying Asset Management has 4 recorded portfolio companies, including Biosion, Newrite Medical, Arthur Pharma, Biosun Pharma.